Skip to content

Evaluation of the Correlation between Ocular Morphology and Clinical Characteristics in Patients with Chronic Obstructive Pulmonary Disease Using Optical Coherence Tomography Angiography Imaging Technology

Optical Coherence Tomography Angiography in the Assessment of Severity of Chronic Obstructive Pulmonary DiseaseOptical Coherence Tomography Angiography in the Assessment of Severity of Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083035
Enrollment
Unknown
Registered
2024-04-15
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

COPD group, healthy control group:OCTA examination

Sponsors

The First Hospital of Lanzhou University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Patients meet the diagnostic criteria of the COPD guidelines; ? Patients are adults aged =18 years; ? Upon ophthalmic examination, the fundus and retinal structures are normal, intraocular pressure is within 12-20 mmHg, axial length of the eye is within 20-25 mm, and gonioscopy shows an open angle.

Exclusion criteria

Exclusion criteria: ? Patients with glaucoma, hypertensive or diabetic retinopathy, epiretinal membrane, corneal opacity, high myopia or hyperopia (>6D), corneal diseases, history of ocular trauma or surgery, etc.; ? Patients who are unable to cooperate with OCTA examination.

Design outcomes

Primary

MeasureTime frame
The superficial capillary plexus;The deep capillary plexus;Retinal nerve fiber layer;Radial peripapillary capillary;

Secondary

MeasureTime frame
the foveal avascular zone area;the foveal avascular zone perimeter;

Countries

China

Contacts

Public ContactHong GUO

The First Hospital of Lanzhou University.

839943643@qq.com+86 138 9347 5589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026